LSERS
COLL icon

Louisiana State Employees Retirement System’s Collegium Pharmaceutical COLL Stock Holding History

Louisiana State Employees Retirement System’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$514K Buy
14,200
+200
+1% +$6.83K 0.01% 1391
2026
Q1 		$463K Sell
14,000
-500
-3% -$21.2K 0.01% 1370
2025
Q4 		$671K Hold
14,500
– – 0.01% 1230
2025
Q3 		$507K Sell
14,500
-500
-3% -$17.4K 0.01% 1329
2025
Q2 		$444K Sell
15,000
-200
-1% -$5.71K 0.01% 1356
2025
Q1 		$454K Sell
15,200
-400
-3% -$12.2K 0.01% 1357
2024
Q4 		$447K Hold
15,600
– – 0.01% 1372
2024
Q3 		$603K Sell
15,600
-900
-5% -$32.1K 0.01% 1285
2024
Q2 		$531K Buy
16,500
+300
+2% +$10.4K 0.01% 1309
2024
Q1 		$629K Sell
16,200
-100
-0.6% -$3.5K 0.01% 1259
2023
Q4 		$502K Sell
16,300
-1,400
-8% -$35.1K 0.01% 1332
2023
Q3 		$396K Sell
17,700
-500
-3% -$11.4K 0.01% 1373
2023
Q2 		$391K Buy
18,200
+2,600
+17% +$59K 0.01% 1383
2023
Q1 		$374K Sell
15,600
-300
-2% -$7.96K 0.01% 1341
2022
Q4 		$369K Sell
15,900
-400
-2% -$8.07K 0.01% 1342
2022
Q3 		$261K Sell
16,300
-100
-0.6% -$1.76K 0.01% 1416
2022
Q2 		$277K Sell
16,400
-400
-2% -$6.73K 0.01% 1423
2022
Q1 		$303K Buy
16,800
+100
+0.6% +$1.89K 0.01% 1438
2021
Q4 		$312K Sell
16,700
-400
-2% -$7.8K 0.01% 1446
2021
Q3 		$338K Buy
17,100
+1,200
+8% +$25.9K 0.01% 1423
2021
Q2 		$376K Buy
15,900
+100
+0.6% +$2.31K 0.01% 1386
2021
Q1 		$374K Buy
+15,800
New +$375K 0.01% 1376

Other funds holding COLL

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return
AFAS
Acorn Financial Advisory Services Reston, Virginia $753M AUM 36.94% 1-Year Est. Return
SIM
SummerHaven Investment Management Stamford, Connecticut $187M AUM 70.61% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Louisiana State Employees Retirement System's COLL Position: Q2 2026 in Review

Louisiana State Employees Retirement System increased its Collegium Pharmaceutical (COLL) stake by 1.4% in Q2 2026, buying an estimated $6.83K and bringing the position to 14,200 shares worth $514K. The position accounts for 0.01% of the portfolio, ranked #1391.

Louisiana State Employees Retirement System first reported a position in COLL in Q1 2021 and has held it in 22 quarters since. The position peaked at $671K in Q4 2025. 44 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Louisiana State Employees Retirement System held 14,200 shares of Collegium Pharmaceutical worth $514K as of Q2 2026.
  • Louisiana State Employees Retirement System bought 200 Collegium Pharmaceutical shares in Q2 2026, an estimated $6.83K.
  • Collegium Pharmaceutical made up 0.01% of Louisiana State Employees Retirement System's portfolio in Q2 2026, its #1391 holding.
  • Louisiana State Employees Retirement System first reported a position in Collegium Pharmaceutical in Q1 2021 and has held it in 22 quarters since.
  • Louisiana State Employees Retirement System's Collegium Pharmaceutical position peaked at $671K in Q4 2025.
  • 44 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Louisiana State Employees Retirement System's 13F filing for Q2 2026, filed 20 Jul 2026.